IHH Healthcare Berhad
Market Cap
RM50.6b
Last Updated
2019/10/14 14:58 UTC
Data Sources
Company Financials +
Executive Summary
IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide.
Snowflake
Fundamentals
Reasonable growth potential with adequate balance sheet.
Similar Companies
Share Price & News
How has IHH Healthcare Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
1.9%
IHH
1.8%
MY Healthcare
0.6%
MY Market
1 Year Return
13.1%
IHH
9.6%
MY Healthcare
-6.4%
MY Market
Shareholder returns
| IHH | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.9% | 1.8% | 0.6% |
| 30 Day | 1.9% | 1.4% | -1.3% |
| 90 Day | -0.5% | -1.4% | -5.7% |
| 1 Year | 13.7%13.1% | 10.4%9.6% | -3.1%-6.4% |
| 3 Year | -8.5%-9.8% | -10.0%-11.8% | 2.5%-9.4% |
| 5 Year | 21.3%18.2% | 18.8%14.6% | 1.4%-16.2% |
Price Volatility Vs. Market
How volatile is IHH Healthcare Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Valuation
Is IHH Healthcare Berhad undervalued compared to its fair value and its price relative to the market?
23.1%
Undervalued compared to fair value
Share Price vs. Fair Value
Undervalued: IHH (MYR5.77) is trading below our estimate of fair value (MYR7.51)
Significantly Undervalued: IHH is trading below fair value, but not by a significant amount.
Price To Earnings Ratio
PE vs Industry: IHH is poor value based on its PE Ratio (83.4x) compared to the Healthcare industry average (34x).
PE vs Market: IHH is poor value based on its PE Ratio (83.4x) compared to the MY market (14.4x).
Price to Earnings Growth Ratio
Low PEG Ratio: IHH is poor value based on its PEG Ratio (3.3x)
Price to Book Ratio
PB vs Industry: IHH is good value based on its PB Ratio (2.1x) compared to the MY Healthcare industry average (2.2x).
Next Steps
Future Growth
How is IHH Healthcare Berhad forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
24.9%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IHH's forecast earnings growth (24.9% per year) is above the savings rate (2.7%).
Earnings vs Market: IHH's earnings (24.9% per year) are forecast to grow faster than the MY market (10.5% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IHH's revenue (9.8% per year) is forecast to grow faster than the MY market (5.8% per year).
High Growth Revenue: IHH's revenue (9.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Information is not available.
Next Steps
Past Performance
How has IHH Healthcare Berhad performed over the past 5 years?
-9.9%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: IHH's earnings have declined by -9.9% per year over the past 5 years.
Accelerating Growth: IHH's earnings growth over the past year (81.8%) exceeds its 5-year average (-9.9% per year).
Earnings vs Industry: IHH earnings growth over the past year (81.8%) exceeded the Healthcare industry 9.7%.
Return on Equity
High ROE: IHH's Return on Equity (1.9%) is considered low.
Return on Assets
ROA vs Industry: IHH's Return on Assets is below or equal to the Healthcare industry average last year.
Return on Capital Employed
ROCE Improving: IHH has improved its Return on Capital Employed over the past 3 years.
Next Steps
Financial Health
How is IHH Healthcare Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: IHH's short term assets (MYR7.9B) exceeds its short term liabilities (MYR6.6B)
Long Term Liabilities: IHH's short term assets (7.9B) do not cover its long term liabilities (11.1B)
Debt to Equity History and Analysis
Debt Level: IHH's debt to equity ratio (32.8%) is considered satisfactory
Reducing Debt: IHH's debt to equity ratio has increased from 20.6% to 32.8% over the past 5 years.
Debt Coverage: IHH's debt is well covered by operating cash flow (21.4%).
Interest Coverage: IHH's interest payments on its debt are well covered by EBIT (6.1x coverage).
Balance Sheet
Information is not available.
Information is not available.
Next Steps
Dividend
What is IHH Healthcare Berhad's current dividend yield, its reliability and sustainability?
0.52%
Current Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: IHH's dividend (0.52%) isn’t notable compared to the bottom 25% of dividend payers in the MY market (2.06%).
High Dividend: IHH's dividend (0.52%) is low compared to the top 25% of dividend payers in the MY market (4.95%).
Stable Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are stable.
Growing Dividend: IHH is not paying a notable dividend for the MY market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: IHH is not paying a notable dividend for .
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IHH's dividend in 3 years as they are not forecast to pay a notable one for the MY market.
Next Steps
Management
What is the CEO of IHH Healthcare Berhad's salary, the management and board of directors tenure and is there insider trading?
2.6yrs
Average management tenure
CEO
See Leng Tan (54yo)
5.8yrs
Tenure
RM36,175,000
Compensation
Dr. See Leng Tan serves as the Group Chief Executive Officer and Managing Director at Parkway Pantai Limited. Dr. Tan serves as an Advisor at Clearbridge Accelerator. He has been the Chief Executive Office ...
CEO Compensation Analysis
Information is not available.
Compensation vs Earnings: See Leng's compensation has been consistent with company performance over the past year.
Management Age and Tenure
2.6yrs
Average Tenure
54yo
Average Age
Experienced Management: IHH's management team is considered experienced (2.6 years average tenure).
Board Age and Tenure
2.5yrs
Average Tenure
56yo
Average Age
Experienced Board: IHH's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.
Insider Trading
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Unit Chairman |
| Shares | 3,000,000 |
| Max Price | RM5.65 |
Ownership Breakdown
Management Team
Soon Teck Low (54yo)
Group Chief Financial Officer
- Tenure: 3.8yrs
See Leng Tan (54yo)
CEO, MD & Non-Independent Executive Director
- Tenure: 5.8yrs
- Compensation: RM36.18m
Mehmet Aydinlar (62yo)
- Tenure: 0yrs
- Compensation: RM7.72m
Boon Kheng Chan (51yo)
Group Head of Strategic Planning & Business Development (M&A) and CEO of South East Asia Ops. Div.
- Tenure: 1.8yrs
Suet Wun Lim (59yo)
Group Chief Operating Officer
- Tenure: 1.6yrs
Ching Voon Seow
Company Secretary
- Tenure: 0yrs
Nili Shayrina Saat (44yo)
Head of Risk Management
- Tenure: 0.9yrs
Kelvin Loh (45yo)
Executive Director
- Tenure: 0.3yrs
Abdul Baba (63yo)
President of IMU Health Sdn Bhd and C.E.O. & Vice-Chancellor of IMU Education Sdn Bhd
- Tenure: 3.8yrs
Sharon Lin (50yo)
Group Chief Human Resources Officer
- Tenure: 2.6yrs
Board Members
Shirish Apte (66yo)
Independent Non-Executive Director
- Tenure: 5.1yrs
- Compensation: RM722.00k
Mohammed Bin Hashim (62yo)
Independent Non Executive Chairman
- Tenure: 1.8yrs
- Compensation: RM985.00k
See Leng Tan (54yo)
CEO, MD & Non-Independent Executive Director
- Tenure: 5.8yrs
- Compensation: RM36.18m
Mehmet Aydinlar (62yo)
- Tenure: 0yrs
- Compensation: RM7.72m
Jill Watts (60yo)
Independent Non Executive Director
- Tenure: 1.5yrs
- Compensation: RM337.00k
Koji Nagatomi (58yo)
Non Independent & Non Executive Director
- Tenure: 2.5yrs
- Compensation: RM295.00k
Rossana Binti Ahmad Rashid (53yo)
Independent Non-Executive Director
- Tenure: 7.5yrs
- Compensation: RM867.00k
Kelvin Loh (45yo)
Executive Director
- Tenure: 0.3yrs
Takeshi Saito (47yo)
Non-Independent & Non-Executive Director
- Tenure: 0.6yrs
- Compensation: RM148.00k
Chinta Bhagat (50yo)
Non-Independent Non-Executive Director
- Tenure: 3.1yrs
- Compensation: RM626.00k
Company Information
IHH Healthcare Berhad's company bio, employee growth, exchange listings and data sources
Key Information
- Name: IHH Healthcare Berhad
- Ticker: IHH
- Exchange: KLSE
- Founded: 2010
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: RM50.626b
- Shares outstanding: 8.77b
- Website: https://www.ihhhealthcare.com
Number of Employees
Location
- IHH Healthcare Berhad
- Pantai Hospital Kuala Lumpur
- Level 11, Block A
- Kuala Lumpur
- Wilayah Persekutuan
- 59100
- Malaysia
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IHH | KLSE (Bursa Malaysia) | Yes | Ordinary Shares | MY | MYR | Jul 2012 |
| Q0F | SGX (Singapore Exchange) | Yes | Ordinary Shares | SG | SGD | Jul 2012 |
| IHHH.F | OTCPK (Pink Sheets LLC) | Yes | Ordinary Shares | US | USD | Jul 2012 |
Biography
IHH Healthcare Berhad, an investment holding company, provides healthcare services worldwide. The company operates in seven segments: Singapore, Malaysia, India, North Asia, Acibadem Holdings, IMU Health, ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/14 14:58 |
| End of Day Share Price | 2019/10/14 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.